american diabetes association 'history of pancreatitis' glp-1 receptor agonist Risk all–cause death and pancreatic events following RA initiation in people with obesity or type 2 diabetes: observations from a federated research network | Cardiovascular Diabetology Use of glucagon-like peptide-1 receptor

10.1016/S0378-4274(99)00230-1 80 TangW

Patients currently using tirzepatide weight loss programs or semaglutide wellness programs sometimes begin exploring recovery-focused peptide therapy during maintenance phases or long-term wellness planning

[51] reported a randomized double-blind, placebo-controlled multi-centric trial with hundred of patients with low volume localized prostate cancers, followed by an active surveillance, where dutasteride and placebo were administered randomly on 1:1 basis for three years

Interesting questions have been raised during the investigation of PLC role in development of skin cancer